Novel cationic lipoplexes in gene delivery by Laakko, Maria
  
 
 
 
 
 
 
 
 
 
NOVEL CATIONIC LIPOPLEXES IN GENE DELIVERY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maria Laakko 
University of Helsinki 
Faculty of Pharmacy 
Division of Pharmaceutical Biosciences 
May 2017 
  
Tiedekunta/Osasto Fakultet/Sektion – Faculty 
 Faculty of Pharmacy 
Osasto/Sektion– Department 
Division of Pharmaceutical Biosciences 
Tekijä/Författare – Author 
Maria Laakko 
Työn nimi / Arbetets titel – Title 
Novel cationic lipoplexes in gene delivery 
Oppiaine /Läroämne – Subject 
Biopharmacy 
Työn laji/Arbetets art – Level 
Master’s thesis 
Aika/Datum – Month and year 
May 2017 
Sivumäärä/ Sidoantal – Number of pages 
60 + 1 
Tiivistelmä/Referat – Abstract 
Gene therapy is the therapeutic delivery of nucleic acid sequences into cells, where they can 
replace a gene that is missing, mutated or poorly expressed. It is a potential treatment to cure e.g. 
genetic diseases, viral infections and various cancers. The nucleic acid needs to be delivered 
across the cell membrane and into the nucleus to affect the gene expression. Anionic nucleic acids 
need a cationic carrier, such as a cationic liposome, to enable their delivery into the cells. The 
liposomes used in gene delivery usually contain both a cationic lipid to associate with the nucleic 
acid and a neutral helper lipid to stabilize the structure. The liposome-nucleic acid complex is 
called a lipoplex. The cationic carrier must include or function as a cell-penetrating enhancer 
(CPE) to be able to translocate across the cell membrane into the cytosol and to the nucleus. 
 
The experimental part of this work was aimed at developing and characterizing an innovative 
poly-cationic liposomal platform for gene delivery, using a novel synthetic CPE. The CPE used 
in this study is an oligo-guanidyl derivative (OGD) that had either 4 (OGD4) or 6 (OGD6) cationic 
charges. Liposomes were surface-engineered with OGD, obtaining a cationic formulation that 
was then exploited for DNA loading. The study has two main characterization steps: Step 1 was 
to decorate liposomes with OGD by post insertion using increasing amounts of OGD, and 
determine the vesicle size and zeta potential by dynamic light scattering (DLS). Step 2 involved 
DNA loading by post insertion into the cationic liposomes with increasing amounts of DNA. The 
lipoplex size and zeta potential was determined by DLS, the complexation by electrophoresis, 
and the thermodynamics of the cationic liposome/DNA association by isothermal titration 
calorimetry (ITC). The measurements were performed in isotonic buffers (HEPES pH 7.4 and 
citrate pH 5) and in lower ionic strength TRIS buffer (pH 7.4). 
 
The aim of the characterization studies was first to find a liposome composition that includes just 
enough OGD to obtain a sufficiently high zeta potential and a uniform, sufficiently small size. 
The optimal formulation contained either 10 % of OGD4 or 5 % of OGD6 of the total lipid 
amount. The second step was to find the highest stable DNA loading for the lipoplexes. All the 
characterization studies were performed on OGD4 lipoplexes in TRIS buffer. The optimal 
OGD4/DNA N/P (nitrogenous/phosphorous) ratio was found to be around 5.  
 
Further investigation is needed to determine the best lipoplex composition and manufacturing 
method using an isotonic buffer. A DNA release study remains to be performed prior to further 
in vitro and in vivo studies. 
Avainsanat – Nyckelord – Keywords 
Lipoplex, gene delivery, dynamic light scattering (DLS), electrophoresis, isothermal titration 
calorimetry (ITC) 
Säilytyspaikka – Förvaringställe – Where deposited 
Division of Pharmaceutical Biosciences 
Muita tietoja – Övriga uppgifter – Additional information 
Supervisors: Stefano Salmaso and Tapani Viitala 
 Tiedekunta/Fakultet – Faculty 
 Farmasian tiedekunta 
Osasto/Sektion– Department 
Farmaseuttisten biotieteiden osasto 
Tekijä/Författare – Author 
Maria Laakko  
Työn nimi/Arbetets titel – Title 
Uudet kationiset lipopleksit geenien annostelussa  
Oppiaine /Läroämne – Subject 
Biofarmasia 
Työn laji/Arbetets art – Level 
Pro gradu 
Aika/Datum – Month and year 
Toukokuu 2017 
Sivumäärä/ Sidoantal – Number of pages 
 60 + 1 
Tiivistelmä/Referat – Abstract 
Geeniterapia on nukleiinihappojen annostelua kohdesoluihin, joissa ne korvaavat puuttuvan, 
vaurioituneen tai heikosti ilmentyvän geenin. Geeniterapia voisi tulevaisuudessa toimia vaikeiden 
sairauksien, kuten geneettisten sairauksien, virusinfektioiden tai useiden syöpien, hoitomuotona. 
Nukleiinihapon tulee läpäistä solukalvo ja päästä tumaan vaikuttaakseen geenien ilmentymiseen. 
Negatiivisesti varautuneet nukleiinihapot tarvitsevat positiivisesti varautuneen kantajan, kuten 
kationisen liposomin, päästäkseen solujen sisään. Geenien annostelussa käytetyt liposomit 
sisältävät yleensä kationisen lipidin, johon nukleiinihappo kiinnittyy, ja neutraalin apulipidin 
stabiloimaan rakennetta. Liposomi-nukleiinihappokompleksia kutsutaan lipopleksiksi.  
Kationisen kantajan tulisi sisältää tai toimia lisäksi soluun pääsyn edistäjänä (cell-penetrating 
enhancer, CPE), joka auttaa nukleiinihappoa siirtymään solukalvon läpi ja edelleen tumaan.  
  
Työn kokeellisessa osuudessa kehitettiin ja tutkittiin uutta polykationista liposomialustaa geenien 
annosteluun, käyttäen uutta synteettistä CPE:tä. Tässä tutkimuksessa käytetty CPE on oligo-
guanidyylijohdannainen (OGD), jolla on joko 4 (OGD4) tai 6 (OGD6) kationista varausta. 
Liittämällä liposomiin OGD:tä saatiin positiivisesti varautunut formulaatio, joka sitten lastattiin 
DNA:lla. Karakterisointi sisälsi kaksi vaihetta. 1. vaihe oli OGD:n liittäminen valmiisiin 
liposomirakkuloihin kasvavina määrinä ja rakkulan koon sekä zetapotentiaalin määritys 
dynaamisella valosirontamenetelmällä (DLS:llä). 2. vaihe sisälsi DNA:n lastaamisen kationiseen 
liposomiin kasvavina määrinä. Lipopleksin koko ja zetapotentiaali määritettiin DLS:llä, 
kompleksoituminen elektroforeesilla ja sitoutumisen termodynamiikka isotermaalisella 
titraatiokalorimetrialla (ITC:llä). Mittauksia tehtiin sekä isotonisilla puskureilla (HEPES pH 7.4 
ja sitraatti pH 5) että pienemmän ionivahvuuden TRIS-puskurilla (pH 7.4). 
 
Karakterisoinnin tavoitteena oli löytää liposomiformulaatio, jossa pienimmällä mahdollisella 
määrällä OGD:tä saatiin riittävän korkea zetapotentiaali sekä riittävän pieni ja tasainen 
partikkelikoko. Optimaalinen formulaatio sisälsi joko 10 % OGD4:ä tai 5 % OGD6:a 
kokonaisliposomien määrästä. Toisena tavoitteena oli selvittää, kuinka suuri määrä DNA:ta 
kompleksoituu kationiseen liposomiin. OGD4-lipoplekseille TRIS-puskurissa tehtiin kaikki 
analyysit. OGD4:n ja DNA:n optimaaliseksi N/P (typpi/fosfori) suhteeksi saatiin noin 5.  
 
Lisätutkimuksia tarvitaan selvittämään paras lipopleksien valmistusmenetelmä ja koostumus 
isotonisessa puskuriliuoksessa. Lisäksi DNA:n vapautumiskokeet pitää tehdä ennen in vitro- ja 
in vivo-lisätutkimuksia.  
Avainsanat – Nyckelord – Keywords 
Lipopleksi, geenien annostelu, dynaaminen valosironta (DLS), elektroforeesi, isotermaalinen 
titraatiokalorimetria (ITC) 
Säilytyspaikka – Förvaringställe – Where deposited 
 Farmaseuttisten biotieteiden osasto 
Muita tietoja – Övriga uppgifter – Additional information 
Ohjaajat: Stefano Salmaso ja Tapani Viitala 
  
ACKNOWLEDGEMENTS 
 
The experimental part of my Master’s thesis was done in the Department of 
Pharmaceutical and Pharmacological Sciences in the University of Padova in Italy. This 
research project was an integral part of the research collaboration between Dr. Tapani 
Viitala’s and Prof. Stefano Salmaso’s research groups. 
 
First, I want to thank my supervisors Dr. Tapani Viitala and Prof. Stefano Salmaso for 
enabling this work. I am very grateful for Dr. Viitala’s and Prof. Marjo Yliperttula’s 
support and guidance during the project. Special thanks to Alessio Malfanti for tutoring 
and helping me in the laboratory.  
 
I am grateful for Elena Ambrosio’s help in performing the ITC measurements. Thank 
you, Silvia Gallina, for peer support. Also, thanks to Dr. Anna Balasso for your help in 
analyzing the liposomes. I am sincerely grateful to the whole research group in Prof. 
Salmaso’s laboratory, you made my stay and work fun, and also helped me learn Italian.  
 
Special thanks to my family Leena, Ilkka and Eveliina for endless support over the years. 
I want also to thank my friends who have been there for me when I have needed them. 
My greatest gratitude is dedicated to my friend Ville who reviewed the text, supported 
and encouraged me, and gave me constructive criticism during the work. 
 
Helsinki, May 2017 
 
Maria Laakko  
 TABLE OF CONTENTS 
 
1 INTRODUCTION ......................................................................................................... 1 
2 LITERATURE REVIEW .............................................................................................. 2 
2.1 Lipoplexes ............................................................................................................... 2 
2.1.1 Liposomes ........................................................................................................ 2 
2.1.2 Cationic liposomes in gene delivery ................................................................ 6 
2.1.3 Lipofectamine .................................................................................................. 8 
2.2 Cell-penetrating enhancers ..................................................................................... 8 
2.2.1 Cell penetrating peptides ................................................................................. 8 
2.2.2 Applications of cell-penetrating peptides in gene delivery ............................. 9 
2.2.3 Novel non-peptide cell-penetrating enhancer ................................................ 10 
2.3 Characterization methods ..................................................................................... 11 
2.3.1 Dynamic Light Scattering for particle size measurements ............................ 11 
2.3.2 Zeta potential ................................................................................................. 15 
2.3.2 One-dimensional gel electrophoresis ............................................................. 18 
2.3.3 Isothermal titration calorimetry ..................................................................... 20 
3 AIM OF THE STUDY ................................................................................................ 22 
4 MATERIALS AND METHODS ................................................................................. 23 
4.1 Novel cationic lipoplexes ...................................................................................... 23 
4.2 Buffer preparation ................................................................................................. 25 
4.3 Liposome preparation and different characterization methods ............................. 28 
4.3.1 Post-insertion of oligo-guanidyl derivative ................................................... 29 
4.3.2 Post-insertion of double stranded DNA ......................................................... 30 
4.3.2 Size and zeta potential measurements with dynamic light scattering ............ 30 
4.3.3 Electrophoretic mobility shift assay .............................................................. 31 
4.3.4 Isothermal titration calorimetry ..................................................................... 33 
5 RESULTS .................................................................................................................... 34 
5.1 Dynamic light scattering results for OGD4 .......................................................... 34 
5.2 Electrophoretic mobility shift assay for OGD4 .................................................... 41 
5.3 Isothermal titration calorimetry for OGD4 ........................................................... 41 
5.4 Dynamic light scattering results for OGD6 .......................................................... 46 
5.5 Electrophoretic mobility shift assay for OGD6 .................................................... 50 
6 DISCUSSION .............................................................................................................. 50 
6.1 Characterization studies ........................................................................................ 50 
6.2 Future perspectives ............................................................................................... 53 
7 CONCLUSION ............................................................................................................ 54 
BIBLIOGRAPHY ........................................................................................................... 56 
 
APPENDIX A: Isothermal titration calorimetry raw data 
 
 
  
 LIST OF ABBREVIATIONS 
 
APS ammonium persulfate 
CPE cell-penetrating enhancer 
CPP cell-penetrating peptide 
DLS  dynamic light scattering 
DNA deoxyribonucleic acid 
dsDNA double stranded DNA 
DOPE Dioleoylphosphatidylethanolamine 
EDL electric double layer 
EDTA ethylenediaminetetraacetic acid 
EggPC egg phosphatidylcholine 
FBS fetal bovine serum 
HEPES 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid 
HSPC hydrogenated soy phosphatidylcholine 
ITC isothermal titration calorimetry 
LUV large unilamellar vesicles 
MPS mononuclear phagocyte system 
OGD oligo-guanidyl derivative 
PEG polyethylene glycol  
RES reticuloendothelial system 
RNA ribonucleic acid 
siRNA small interfering RNA 
sla-DLS single large scattering angle DLS 
SUV small unilamellar vesicles 
TAT trans-activator of transcription 
TBE TRIS, boric acid and EDTA 
TEMED N,N,N′,N′-tetramethylethylenediamine 
TRIS 2-Amino-2-(hydroxymethyl)-1,3-
propanediol base 
1 
 
1 INTRODUCTION  
 
Gene therapy is the therapeutic delivery of nucleic acid sequences into cells  (Alhakamy 
et al. 2013). It is a potential treatment to cure e.g. genetic diseases, viral infections and 
various cancers. Research in this field has become popular and it has seen remarkable 
development in recent years (Nayerossadat et al. 2012; Alhakamy et al. 2013). The 
genetic material needs to be delivered across the cell membrane and into the nucleus using 
either a viral or a non-viral vector as a delivery system. This Master’s thesis focus on the 
non-viral vectors, especially liposomes.  
 
In general, anionic oligonucleotides, such as deoxyribonucleic acid (DNA) and 
ribonucleic acid (RNA), need a cationic carrier to enable their delivery into the cells 
(Nayerossadat et al. 2012; Alhakamy et al. 2013). The cationic carrier must include a cell-
penetrating enhancer (CPE) to be able to translocate across the cell membrane into the 
cytosol and to the nucleus. The liposomes used in gene delivery usually contain both a 
cationic lipid to associate with the DNA or RNA and a neutral helper lipid to stabilize the 
structure. The liposome-oligonucleotide complex is called a lipoplex. The cell penetrating 
enhancer can be either peptide-based (a cell penetrating peptide (CPP)) or a non-peptide 
molecule with cell penetrating properties (Bersani et al. 2012).  
 
In this thesis, a novel cationic synthetic cell penetrating enhancer designed to anchor to 
either liposomal or polymer carriers is used (Bersani et al. 2012). The novel CPE is first 
anchored to a liposomal platform and then DNA is introduced to the surface-engineered 
liposomes to create a lipoplex. Studies concerning the manufacturing of the cationic 
liposomes, their physico-chemical properties, and their association to DNA by using 
various techniques are performed.  
 
The literature review of this Master’s thesis focuses on the materials and characterization 
methods used in this study. Liposome structure, cell penetrating enhancers, and the use 
of cationic liposomes in gene delivery are explained. This is followed by an overview of 
the measurement techniques used: dynamic light scattering, zeta potential, mobility shift 
electrophoresis and isothermal titration calorimetry. The experimental part is focused on 
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characterizing the novel cationic liposome composition and their DNA association 
properties using the aforementioned techniques. This Master´s thesis is then concluded 
with the summary of the results and suggestions for further studies. 
 
 
2 LITERATURE REVIEW 
 
This literature review gives a general overview of the materials and the measurement 
techniques relevant to this study, specifically liposomes, lipoplexes, cell penetrating 
peptides, dynamic light scattering, zeta potential, gel electrophoresis and isothermal 
titration calorimetry.  
 
2.1 Lipoplexes 
 
2.1.1 Liposomes 
 
Liposomes are spherical lipid vesicles whose dimension varies from 30 to 2500 nm, and 
are classified according to their diameter and structure (Akbarzadeh et al. 2013; Allen 
and Cullis 2013). Liposomes are classified in multilamellar and unilamellar vesicles as 
shown in Figure 1. There are also two categories of unilamellar vesicles: large unilamellar 
vesicles (LUV) and small unilamellar vesicles (SUV). Unilamellar vesicles have a single 
lipid bilayer, while multilamellar vesicles can have several lipid bilayers. The basic 
structure of a unilamellar vesicle is shown in Figure 2. LUVs are prepared by extrusion 
through polycarbonate filters from multilamellar vesicles. Multilamellar vesicles need to 
be sonicated before the extrusion to obtain SUVs. Liposomes can also be classified by 
composition and mechanism of drug delivery to conventional, long-circulating, 
polymorphic (pH-sensitive, thermosensitive, and cationic liposomes), and decorated 
liposomes (surface-modified liposomes and immunoliposomes) (Lopes et al. 2013). 
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Figure 1. Liposome classification: Multilamellar vesicles on the bottom and two types of 
unilamellar vesicles and their vesicle diameter on the top of the figure (Lopes et al. 2013). 
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Figure 2. The basic structure and composition of unilamellar liposomes (Frézard et al. 
2007). 
 
Bangham et al.  (1965) were the first to discover liposomes in the 1960s when they studied 
swollen phospholipid systems that became the basic model of membrane systems. In their 
study, they discovered that the phospholipids form hollow vesicles with a phospholipid 
bilayer where the polar heads are oriented towards the interior and exterior aqueous 
phases and the lipophilic tails heading inside the lipid bilayer. At the beginning of 1970s 
Gregoriadis  (1973) discovered that both water-soluble and lipid-soluble substances can 
be entrapped in the aqueous or lipid phase of liposomes, respectively. The elimination 
time from the blood for liposome-entrapped drugs is longer than for non-entrapped drugs. 
They studied liposomes that contained a phospholipid, cholesterol and either stearylamine 
(cationic liposomes) or phosphatidic acid (anionic liposomes). 
 
Liposomes have many advantages, such as biocompatibility, biodegradability, low 
toxicity, and ability to trap both hydrophilic and lipophilic compounds (Akbarzadeh et al. 
2013). Therefore, liposomes are becoming more common as a drug delivery system. 
Liposomes can also reduce drug toxicity, increase efficacy and therapeutic index of drugs, 
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increase stability, reduce the exposure of sensitive tissues to toxic drugs, and help 
targeting specific cells. Of course, liposomes have also some disadvantages that need to 
be considered when using it as a drug carrier. These are low solubility, short half-life, 
leakage and fusion of encapsulated drugs or molecules, high production cost, and 
sometimes the phospholipids experience oxidation and hydrolysis-like reactions.  
 
The drugs can be loaded to liposomes either passively during the liposome formation or 
actively after the liposome formation (Akbarzadeh et al. 2013; Allen and Cullis 2013). 
Lipid-soluble drugs can be passively combined into liposomes during vesicle formation. 
Instead, passive loading during vesicle formation of water-soluble drugs is depending on 
the ability of liposomes to entrap aqueous buffer that contains the drug. Loading after the 
liposome formation is active and independent of the time and site of liposome 
manufacture. Water-soluble drugs can be loaded actively to liposome by the effect of pH 
gradient. The drug retention in liposomes is drug dependent. 
 
Conventional liposomes are not very stable in vivo because of their rapid clearance from 
circulation by the mononuclear phagocytic system (MPS), also known as 
reticuloendothelial system (RES) (Allen and Cullis 2013). Circulation half-life can be 
extended by using large doses of empty liposomes before introducing liposomes with the 
drug, or by reducing the vesicle size. The first long circulating liposomes, that did not 
need MPS blockade to achieve the effect, were composed of egg phosphatidylcholine 
(EggPC) and cholesterol, and addition of the monosialylganglioside GM1. A simpler way 
to prepare long circulating liposomes is to coat them with polyethylene glycol (PEG) 
(Akbarzadeh et al. 2013; Allen and Cullis 2013). PEG coating helps avoiding liposome 
recognition by the MPS because it inhibits protein adsorption and opsonization of 
liposomes (Gabizon 2001). These long circulating liposomes are called stealth liposomes. 
They have a phospholipid bilayer as a membrane and are used for drug or gene delivery 
into cells (Akbarzadeh et al. 2013; Allen and Cullis 2013). It has been discovered that 
PEG-liposomes have dose-independent clearance at normal doses.    
 
Intracellular delivery of drugs is both a limitation and a benefit for liposomal drug carriers 
(Akbarzadeh et al. 2013; Allen and Cullis 2013). For macromolecules, such as small 
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interfering RNA (siRNA), and peptides that do not enter cells on their own, intracellular 
delivery is an essential prerequisite to achieve therapeutic activity. There is two ways to 
mediate this internalization, either by including antibodies or other ligands or via 
fusogenic agents. Liposomes interact with cells mainly by adsorption or endocytosis. A 
less common type of liposomal interaction with cells is fusion with the cell membrane. 
These liposomes contain fusogenic lipids or membrane-active peptides that can disrupt 
the cell membrane to induce the cytoplasmic delivery of the drug. When the therapeutic 
molecule can survive the acidic and enzyme-rich environment of the endosomes and 
lysosomes, then the most common way to introduce molecules into the cell interior is 
receptor-mediated endocytosis of ligand-targeted liposomes. Antibodies are usually used 
as a ligand for targeted liposomes. These antibody-targeted liposomes can improve the 
selective toxicity of anticancer agents but, their in vivo distribution to non-MPS tissues is 
limited by rapid clearance form circulation. Ligand-targeted liposomes do not have many 
advantages over passively targeted (i.e. ‘non’-targeted) liposomes, and improvements in 
survival are often due to increased receptor-mediated uptake of the liposomes containing 
the entrapped drug.  
 
2.1.2 Cationic liposomes in gene delivery 
 
Gene therapy is the therapeutic delivery of large nucleic acid macromolecules  (Alhakamy 
et al. 2013). It has become a popular research topic because of its potential to treat severe 
and challenging diseases, such as genetic diseases, viral infections and various cancers. 
In gene therapy, genetic material can be delivered into a target cell to replace a gene that 
is missing, mutated or poorly expressed. Alternatively, siRNA can be used to silence the 
expression of specific genes. 
 
When cationic liposomes or micelles are complexed with oligonucleotides, such as 
double stranded DNA (dsDNA) and siRNA, the complex is called a lipoplex 
(Nayerossadat et al. 2012). Lipoplexes and polyplexes (the complex between a cationic 
polymer and nucleic acids) can act as chemical non-viral delivery systems for genes. Non-
viral delivery systems are less efficient than viral systems in gene transduction, but their 
advantages compared to viral systems are cost-effectiveness, availability, lower induction 
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of the immune system, and no limitation on the size of the transgenic DNA. Besides, 
cationic liposomes are less toxic and antigenic than viral vectors or other non-viral 
delivery systems because they are made of only biological lipids. The positive charge on 
the cationic liposome surface develops an electrostatic interaction with the negatively 
charged nucleic acids and facilitates contact with the negatively charged cell membranes 
(Dalby et al. 2004). Cationic polymers vary from cationic lipids, since they do not contain 
a hydrophobic moiety and are completely soluble in water (Tros de Ilarduya et al. 2010). 
They can also be synthesized in different lengths and geometries. It is also possible to add 
functional groups to polymers with relative ease and flexibility. 
 
Cationic liposomes are at present the most essential non-viral polycationic systems for 
gene delivery (Nayerossadat et al. 2012). Cationic liposomes are usually composed of a 
cationic lipid, i.e. DOTAP (1,2-dioleoyl-3-trimethylammonium-propane (chloride salt)), 
and a neutral lipid, i.e. dioleoylphosphatidylethanolamine (DOPE) or cholesterol. Their 
unique characteristics include the capability to incorporate both hydrophilic and 
hydrophobic drugs, low toxicity, no immune system activation, and targeted delivery of 
bioactive compounds to the site of action. As mentioned earlier, the disadvantages of 
liposomes are their rapid elimination by RES and their inability to achieve constant drug 
delivery over a prolonged period of time. These issues can be overcome by coating the 
liposomes with PEG or integrating the pre-encapsulated drug-loaded liposomes within 
depot polymer-based systems. 
 
Cholesterol or DOPE is usually used as a helper lipid when using liposomes for gene 
delivery to facilitate the lipid exchange and membrane fusion between lipoplexes and the 
endosomal membrane by unstabilizing it (Nayerossadat et al. 2012). Cationic liposomes 
that contained cholesterol as a helper lipid are structurally more stable in physiologic 
media (Tros de Ilarduya et al. 2010). Therefore, cholesterol containing lipoplexes can 
reach their target tissue flawlessly, protect the DNA from degradation, and facilitate 
transfection. The efficiency of gene delivery in liposomes depends on the size, structure, 
and charge ratio between the oligonucleotide and the cationic liposome, presence of a 
helper lipid, and the cell type.  
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2.1.3 Lipofectamine 
 
Lipofectamine is a commercial cationic liposome based reagent that has a high 
transfection efficiency for nucleic acids (Dalby et al. 2004; Cardarelli et al. 2016).  
Lipofectamine can complex and carry negatively charged nucleic acid molecules. It also 
allows them to overcome the electrostatic repulsion of the cell membrane and to be taken 
up by the cell. In RNA interference studies, synthetic siRNA has been transfected into 
mammalian cells by using Lipofectamine 2000. 
 
In a recent study Rasoulianboroujeni et al. (2017) demonstrated that cationic liposomes 
can be used to transfect and express the LacZ-gene (part of the E. coli lac operon) 
approximately equally to Lipofectamine 2000. Their cationic liposomes consisted of 
DOTAP/DOPE/cholesterol with a molar ratio of 1:1:2, and they used a modified lipid 
film hydration method consisting of a lyophilization step for gene delivery applications. 
 
2.2 Cell-penetrating enhancers 
  
2.2.1 Cell penetrating peptides  
 
Cell-penetrating peptides (CPPs) are short arginine-rich amino acid sequences (less than 
30 amino acids) that can translocate the cellular membranes and access the cell interior 
(Järver and Langel 2006; Herce and Garcia 2007; Herce et al. 2014). CPPs can descend 
from naturally occurring peptide sequences or be synthetized ex novo. They are also 
known as protein transduction domains (PTDs), Trojan peptides or membrane 
translocating sequences (MTS). CPPs can carry a wide range of different sized bioactive 
molecules such as proteins, peptides, oligonucleotides, and even 200 nm nanoparticles 
like liposomes (Torchilin et al. 2001; Järver and Langel 2006; Herce and Garcia 2007). 
They have a large net positive charge and therefore they can penetrate almost any cell. 
Significant differences between different CPPs are size, amino acid sequence, and charge, 
but their common characteristics are the ability to rapidly translocate the plasma 
membrane and enable the delivery of their payload to the cytoplasm or nucleus (Järver 
and Langel 2006). 
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The first observation of CPPs was made in 1988, when the trans-activator of transcription 
(TAT) protein was isolated from the HIV-1 virus (Frankel and Pabo 1988). The TAT 
protein was shown to have the ability to enter the cells and translocate to the nucleus. The 
cellular uptake can follow two different pathways: translocation across the cell membrane 
directly (energy-independent pathway) or endocytosis followed by release into the 
cytosol (energy-dependent pathway) (Järver and Langel 2006; Herce and Garcia 2007). 
Early studies on CPP translocation suggested that they use an energy-independent 
pathway to translocate across the cell membrane. These suggestions were based on low 
temperature (4 °C) studies, which inhibit the cellular adenosine triphosphate (ATP) pool, 
or on chemically inhibiting the endocytosis receptors. However, later studies have shown 
that some mechanisms of CPP translocation involve extracellular heparan sulfate and 
endocytosis and are therefore mostly energy-dependent. The translocation pathway of 
CPPs depends on their cargo and biophysical properties, even though it seems that the 
endosomal pathway is the major route of uptake.  
 
2.2.2 Applications of cell-penetrating peptides in gene delivery  
 
CPPs can be used to enhance the cellular uptake of different biomolecules or vectors such 
as oligonucleotides, liposomes, peptides, proteins and viruses (Alhakamy et al. 2013). 
Non-viral vectors have difficulties in overcoming the barriers between the administration 
site and the nuclei of the target cells. These barriers include, for example, efficient cellular 
uptake, chemical stability of the genetic material and its delivery vesicle, and escape from 
the endosomal network before degradation within lysosomes. To achieve efficacious non-
viral gene delivery the challenge is to overcome these barriers. CPPs can transport various 
biomolecules across the cell membrane, and therefore they are an attractive option for 
helping non-viral vectors in gene delivery to overcome some of the barriers.  
 
Positively charged CPPs interact through electrostatic interaction with the negatively 
charged oligonucleotides (e.g. dsDNA and siRNA) (Alhakamy et al. 2013). This process 
helps to condensate the genetic material and protect it from nuclease enzyme digestion. 
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It can also lead to small nanoparticles with a net positive charge that is able to interact 
with negatively charged moieties on cell surfaces.   
 
Cellular uptake of CPP nanoparticles is influenced by the chemical nature of cationic 
residues (Alhakamy et al. 2013). Arginine-rich CPPs tend to be more efficient than lysine-
rich CPPs in mediating the cell uptake. Polyarginine peptides can interact electrostatically 
with both siRNA and dsDNA. For delivery of genetic material and condensation of 
oligonucleotides into stable complexes it would be good to have a chain of at least six 
amino acids. Usually four-five arginine residues are involved in forming the complexes 
with oligonucleotides, and the extra arginine residues are available for interaction with 
the cell membrane. Transfection efficiency can be increased to reach the same order of 
magnitude as that of Lipofectamine 2000 by introducing a hydrophobic group to the 
CPPs. 
 
2.2.3 Novel non-peptide cell-penetrating enhancer 
 
The use of CPPs in drug delivery has some difficulties such as unspecific cell delivery, 
low stability, and intrinsic biological activity (Bersani et al. 2012). Bersani et al. (2012) 
decided to try to overcome these problems by designing a novel non-peptide CPE, hepta-
arginyl-N-acetyl-maltotriosylamido-dodecanoic acid (Arg7-Malt-NAcC12 acid). It is a 
non-linear oligo-arginyl with an unusual star-like structure, designed for conjugation to 
large systems, e.g. proteins, oligonucleotides or colloidal drug carriers, to promote their 
cell entry. The star-like CPE contains a variable number of arginine functions attached to 
a maltotriose anchoring structure. By simple chemical protocols the hydroxyl groups of 
the maltotriose can provide for multiple derivatizations with arginyl residues. The 
guanidinium headgroup of arginine is essential for cellular uptake because it interacts 
with membrane phospholipids. Therefore, the novel enhancers were designed to resemble 
the oligo-arginine structure of the TAT transduction domain. The cell translocation of the 
guanidium-rich structures is three times faster than that of TAT. This is because the 
insertion of the novel enhancers into lipid bilayers produces a local membrane distortion 
leading to transient pore formation on the membrane. Arg7-Malt-NAcC12 acid can be 
covalently or electrostatically combined with colloidal therapeutic systems to promote 
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their cellular uptake. The cell penetrating properties of Arg7-Malt-NAcC12 acid derivative 
were evaluated to compare it to other CPPs by labeling the molecules with fluorophores, 
such as fluorescein or rhodamine. Quantitative fluorescence studies and cytofluorimetric 
analyses showed that Arg7-Malt-NAcC12 acid can enter both the human MCF-7 breast 
adenocarcinoma and murine MC3T3-E1 embryonic fibroblast cell lines. 
 
2.3 Characterization methods 
 
2.3.1 Dynamic Light Scattering for particle size measurements 
 
One of the most commonly mentioned factors that are responsible for a range of 
biological effects of nanoparticles is particle size (Bhattacharjee 2016). Dynamic Light 
Scattering (DLS), also known as Photon Correlation Spectroscopy or Quasi-Elastic Light 
Scattering, is a popular tool within the pharmacy community. DLS is non-invasive, 
requires minimal sample preparation and no pre-experimental calibration. The 
instruments are integrated, compact, affordable and user-friendly. A selection of light 
scattering instruments such as Malvern Zetasizer series, Brookhaven NanoDLS series, 
and Microtrac Wave II series have appeared in recent years. In this study, the single large 
scattering angle DLS (sla-DLS) Malvern Zetasizer nanoZS 173° was used. The sla-DLS 
technique is explained below.  
 
DLS measures Brownian motion, which is the random movement of particles in a liquid  
(Technical note 2016). The larger the particles are the slower the Brownian motion. The 
motion of the particles causes the observed intensity of the scattered light to fluctuate. 
The typical scattered intensity fluctuation for large and small particles is illustrated in 
Figure 3. DLS measures the autocorrelation function of the scattered intensity and then 
fits it with a mathematical model to determine the translational diffusion coefficient D of 
the scattering particles, as well as their polydispersity index (PDI). D is related to the 
hydrodynamic diameter d(H) of the particles via the Stokes-Einstein equation, 
 
𝑑(𝐻) =  
𝑘𝑇
3𝜋𝜂𝐷
, (1) 
where k is the Boltzmann’s constant, T is the absolute temperature of the sample, and η 
is the viscosity of the solvent.  
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Figure 3. A typical intensity fluctuation for large and small particles in DLS  (Technical 
note 2016). 
 
The measured hydrodynamic diameter is affected by the size of the particle core, the 
surface structure, the concentration and the ionic strength of the medium (Technical note 
2016). The thickness of the electric double layer called the Debye length (-1) can change 
in different ionic concentration which then affect the particle diffusion speed. The 
changes in the particle surface that affect the diffusion speed change also the apparent 
size of the particle. The changes in the shape of a particle can affect the diffusion speed 
and thus the computed hydrodynamic size. For example, if the diameter of a rod shaped 
particle changes it does not noticeably affect the diffusion speed but changes in the 
particle length will. 
 
The sla-DLS instruments have three major components, a laser, the sample and a light 
detector, which are shown in Figure 4 (Bhattacharjee 2016).  The Malvern Zetasizer Nano 
system uses a laser with a wavelength of 633 nm and either a 173° or 90° detector angle 
(Technical note 2016). Correspondingly the NanoDLS series uses a laser with a 
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wavelength of 638 nm and a 90° detector angle (Brookhaven Instruments 2016). The 173° 
detector angle is also known as backscatter detection and it excludes excess scattered light 
(Bhattacharjee 2016; Technical note 2016). In DLS the autocorrelation function is fitted 
with two different mathematical algorithms, either using the cumulant method or the 
CONTIN algorithm  (Bhattacharjee 2016). The cumulant method is unsuitable for 
heterogeneous polydisperse (particles of varied size in a disperse system) samples and 
therefore the CONTIN algorithm is preferred (Varga et al. 2014; Bhattacharjee 2016). 
Since samples are rarely monodisperse (particles of uniform size in a disperse system), 
the results obtained using the two algorithms differ (Bhattacharjee 2016). The PDI 
estimates the width of the particle size distribution. When the PDI ≤ 0.1 the sample is 
considered to be highly monodisperse, and when it is 0.1–0.4 and > 0.4 the sample is 
considered to be moderately and highly polydisperse, respectively. If the PDI is higher 
than 0.7 the DLS technique might not give reliable size results.  
 
Figure 4. Schematic diagram of the instrumentations of dynamic light scattering (DLS) 
(Bhattacharjee 2016). 
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The size of the nanomedicine is one of the factors that influences its biodistribution after 
entry in the body and therefore the size measurement is crucial for the characterization of 
the nanomaterial (Gaumet et al. 2008). Varenne et al. (2015) standardized and validated 
a protocol of size measurements by DLS for monodisperse stable nanomaterial 
characterization. In the validation of the protocol they studied robustness, repeatability, 
intermediate precision, trueness, and measurement uncertainty for 60 nm and 200 nm 
nanoparticles at 20 °C and 25 °C. The 200 nm particles (close to the size of the particles 
used in this study) were liposomes that contained either egg phosphatidylcholine (EggPC) 
or cholesterol and EggPC. The robustness study included the influence of the temperature 
of the sample, the influence of the analyst, and the volume of the sample. The results 
showed that the temperature of the sample should be within −5 °C of 25 °C and within 
±2.5 °C of 20 °C when the equilibration time is 300 seconds. The influence of the analyst 
and the volume of the sample was evaluated on each standard by using different analysts 
and the minimum and maximum volumes of the cuvette recommended by the supplier of 
the instrument at each temperature. Different analysts or volumes did not cause a 
statistical difference between the size measurements. A procedure is considered to meet 
the requirements when the relative standard uncertainly for the mean value from each size 
measurement is less than 5% according to the ISO 22412:2008 standard (International 
Organization for Standardization 2008). The validation protocol was also shown to have 
good repeatability (Varenne et al. 2015). The trueness was studied using two latex particle 
materials with SI-traceable certified values of 60 and 203 nm obtained by transmission 
electron microscopy. They are spherical nanoparticles that do not swell in aqueous 
dispersions, and appear quite monodisperse by the low PDI (PDI<0.05). The threshold of 
trueness was set at 10% since it was not indicated in the ISO standard. The relative 
standard uncertainty of trueness was less than this threshold for all the cases they studied. 
The confidence interval determined by combining all sources of measurement uncertainty 
was found to meet the standards that were set to this study. 
 
Several studies have used DLS to determine the hydrodynamic size of liposomes (Stiufiuc 
et al. 2015; Kerek and Prenner 2016; Sebaaly et al. 2016; Zuo et al. 2016). Most of them 
have used sla-DLS instruments that use either 90° or 173° scattering angles (Stiufiuc et 
al. 2015; Kerek and Prenner 2016; Sebaaly et al. 2016). The sla-DLS instruments are 
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typically used because the influence of potential “dust contaminations” on the correlation 
functions is significantly reduced (Fischer and Schmidt 2016). Fischer and Schmidt 
(2016) discovered in their study that the size determination by sla-DLS almost always 
yields too small radii when measuring particles such as lipoplexes that exhibit a wide size 
distribution.  
 
2.3.2 Zeta potential 
 
Surface charge is another factor that is responsible for a range of biological effects of 
nanoparticles (Bhattacharjee 2016). Zeta potential, also known as the electrokinetic 
potential, is the potential at the shear or slipping plane of a charged colloidal particle that 
moves towards the oppositely charged electrode owing to electrophoresis (Kaszuba et al. 
2010). The electric double layer (EDL), shown in Figure 5, is formed when a diffuse layer 
consisting of both same and opposite charged ions/molecules grows beyond the Stern 
layer due to the electrostatic field of the charged nanoparticles (Kaszuba et al. 2010; 
Bhattacharjee 2016). The diffuse layer composition is dynamic and varies depending on 
a variety of factors such as pH, ionic strength, concentration etc. 
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Figure 5. A particle in aqueous medium surrounded by the electric double layer. Within 
the diffuse layer the surface of hydrodynamic shear, or the slipping plane, contains the 
ions that move with the particle. The zeta potential is defined as the electric potential at 
the slipping plane (Kaszuba et al. 2010).  
 
Since the zeta potential ζ cannot be measured directly, the instrument is instead used to 
measure the velocity V of the particles in an applied electric field E, which is then used 
to calculate the electrophoretic mobility µe (Bhattacharjee 2016): 
 
𝜇𝑒 =  
𝑉
𝐸
 (2) 
  
The electrophoretic mobility is converted to the zeta potential by using the Helmholtz-
Smoluchowski equation, 
 
𝜇𝑒 =
𝜀𝑟𝜀0𝜁
𝜂
, (3) 
where εr is the relative permittivity/dielectric constant, ε0 the vacuum permittivity, and η 
the viscosity of the sample at the experimental temperature. This equation is used when 
the electric double layer is thin compared to the particle radius and applies to most of the 
pharmaceutical preparations (Kaszuba et al. 2010; Bhattacharjee 2016).  
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The most commonly used technique to determine the electrophoretic mobility of particles 
is light scattering (Kaszuba et al. 2010). Malvern Zetasizer® Nano instruments use laser 
Doppler electrophoresis to measure small frequency shifts in the scattered light that are 
proportional to the speed of the particles (Kaszuba et al. 2010; Bhattacharjee 2016). The 
typical measurement setup is shown in Figure 6. In this technique, the laser beam is split 
into two, one beam is the reference, and the other one is directed towards the sample. The 
Doppler shift is determined when the scattered light from the sample optically interferes 
with the reference beam. Since the laser beam must penetrate the sample, it must be 
optically clear (Kaszuba et al. 2010). 
 
Figure 6. Schematic representation of a typical instrumentation that uses laser Doppler 
electrophoresis to determine the zeta potential of particles (Bhattacharjee 2016). 
 
There are several factors that can influence the zeta potential data. One of the most 
influential parameter is the pH, as the zeta potential becomes more positive or negative 
as a result of acidic or basic pH, respectively (Uskokovic et al. 2010; Bhattacharjee 2016). 
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The zeta potential decreases when the EDL becomes more compressed as the ionic 
strength of a sample increases (Bhattacharjee 2016). The ionic strength affects the 
thickness of the EDL more when the sample concentration is high and therefore it also 
influences the zeta potential values (Kaszuba et al. 2010). Kaszuba et al. (2010) indicate 
that the high concentration zeta potential values are not realistic and therefore should be 
used only in a relative, not absolute sense. Also, the relation between the zeta potential 
and the particle concentration is determined by surface adsorption and the effect of the 
EDL (Bhattacharjee 2016). Even though low concentrations hardly correlate with 
therapeutically relevant doses the most common concentrations for zeta potential 
measurements are 50-100 µg/mL.  
 
Zeta potential is also used to determine the surface charge of nanoparticles although it 
rather deals with surface potential and never measures charge or charge density 
(Bhattacharjee 2016). It also assumes that the dominant ions in the EDL up to the slipping 
plane are similar compared to the particle surface and therefore yields only indicative 
evidence on the nature of surface charge.  
 
2.3.2 One-dimensional gel electrophoresis 
 
One-dimensional gel electrophoresis, also called electrophoretic mobility shift assay, is a 
simple and advantageous method for determining the size, amount, purity, and isoelectric 
point of macromolecules (Shi and Jackowski 1998; Drabik et al. 2013). The separation of 
different macromolecules by electrophoresis happens when the charged molecules 
migrate through a gel matrix upon the application of an electric field. The electric field, 
the ionic strength and the viscosity of the solvent, and the temperature, hydrophobicity, 
shape and size of the molecules affect the constant migration rate: 
 
𝜇 =
𝑉
𝐸
=
𝑍
6𝜋𝜂𝑟
, (4) 
where µ is the electrophoretic mobility, V the migration speed, E the electric field 
strength, Z the total molecular charge, η the viscosity, and r the molecular radius. 
 
One dimensional gel electrophoresis uses two main types of gels, polyacrylamide and 
agarose gels (Drabik et al. 2013). In general, agarose gel is used with large molecules 
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such as in nucleic acid separation, and polyacrylamide gel with smaller molecules like 
proteins, respectively (Shi and Jackowski 1998). When prepared by chemical 
polymerization, the polyacrylamide gel consists of monomeric acrylamide, N,N’-
methylene-bisacrylamide (bisacrylamide), ammonium persulfate (APS), N,N,N′,N′-
tetramethylethylenediamine (TEMED), electrophoretic buffer, and deionized water. 
Monomeric acrylamide and bisacrylamide form the polyacrylamide, and the 
polymerization is initiated by APS and TEMED. The acrylamide monomer is activated 
by APS that forms persulfate free radicals in water, and TEMED is used as the additional 
catalyst because it is capable of carrying electrons.  
 
There are also other types of polyacrylamide gels such as sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE), acid-urea-Triton X-100 (AUT), and 
riboflavin and methylene blue systems (Shi and Jackowski 1998). The rate of 
polymerization and the properties of the gel are affected by several factors. The initiators 
can either accelerate or inhibit the polymerization. Usually the methylene blue system is 
the fastest, then the persulfate system, and the riboflavin system is the slowest. Also in 
chemical polymerization, the higher the initiator concentration the faster is the 
polymerization. Contaminants in reagents can also affect the polymerization rate. For 
example, TEMED contains oxidation products and loses catalytic activity with time, and 
APS solution should be freshly prepared since it is very hygroscopic and decomposes 
when dissolved in water. Since oxygen traps free radicals, it inhibits the acrylamide 
polymerization, and degassing under vacuum is recommended prior to the 
polymerization. 
 
Caglio and Righetti  (1993) discovered in their study that pH has different effect 
depending on the used initiator. The APS-TEMED system gives optimum performance 
between pH 7–10, and no polymerization occurs at pH 4. For the riboflavin-TEMED 
system the optimal pH range for polymerization is between pH 4–7 with a peak about pH 
6.2, and no polymerization occurs at pH 10. The methylene blue system has remarkably 
good performance between pH 4-8, and sufficient performance between pH 9-10. These 
results are important when preparing acrylamide gels. 
 
20 
 
Polyacrylamide gel electrophoresis has been used to study siRNA or dsDNA binding to 
cationic liposomes or different proteins (Geoghegan et al. 2012; Koide et al. 2016). A 
fixed amount of siRNA or dsDNA will bind itself to the cationic liposomes or different 
proteins. Any siRNA or dsDNA that is not or is only loosely attached to the lipoplexes or 
proteins will enter the gel during the electrophoresis. Instead in stable complexes the 
siRNA or dsDNA does not enter the gel. In the Geoghegan et al. (2012) study the non-
specific binding of nucleic acid was enabled by the TAT motifs in PTD-DRBD (protein 
transduction domain - double-stranded RNA binding domain).  
 
2.3.3 Isothermal titration calorimetry 
 
Isothermal titration calorimetry (ITC) is a characterization method that is used to study 
biomolecular interactions (Pierce et al. 1999). It measures the thermodynamic properties 
of biomolecule binding. ITC can determine several reaction parameters, such as the 
binding constant K, reaction stoichiometry N, enthalpy ∆H and entropy ∆S, in a single 
experiment.  
 
ITC is composed of two identical cells  (Pierce et al. 1999). The first cell contains either 
water or buffer and acts as a reference, and the other one contains the sample. The cells 
are placed inside an adiabatic jacket, as shown in Figure 7. The jacket temperature is 
usually 5–10 °C lower than the temperature inside the cells. Both cells have electric 
heaters and temperature sensors. The injection syringe is filled with the titrated ligand, 
and the syringe is then placed into the sample cell. Prior to first injection the reference 
and sample cells are calibrated to the same temperature. The baseline of the experiment 
is given by a constant power (<1 mW) applied to the reference cell. During the injection 
of the titrant the binding reaction either absorbs or releases heat in the sample cell 
depending whether the reaction is endothermic or exothermic, respectively. The heaters 
will compensate for the resulting temperature difference between the cells, and return the 
cells to equal temperature, while the heat flow is measured. 
21 
 
 
Figure 7. Schematic depiction of an isothermal titration calorimeter. 
 
In a single-injection instrument, after the actual titration it is important to perform control 
experiments (Pierce et al. 1999). To determine the heat of dilution of the ligand, it is 
titrated identically into a sample cell containing only the buffer. The less significant 
control experiment determines the heat of dilution of the macromolecule where usually 
buffer is titrated into the sample cell filled with the macromolecule. Since ITC is very 
sensitive it is important to be extremely careful with all aspects of the experiment. Prior 
to the experiment all the solutions and samples need to be degassed under vacuum to 
avoid air bubbles. The initial sample concentrations are critical to accurate interaction 
data. Also, it is important to take into consideration the ionization enthalpy of the buffer 
since a large enthalpy will reflect buffer ionization and protonation. For example, the 
enthalpy of ionization of sodium phosphate buffer is 1 kcal/mol and of TRIS-HCl buffer 
11 kcal/mol. 
 
Several studies have used ITC to determine the interaction between DNA or RNA 
oligonucleotides and cationic liposomes (Kennedy et al. 2000; Pozharski and MacDonald 
2002; Lobo et al. 2003; Nascimento et al. 2015). Kennedy et al. (2000), and Pozharski 
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and MacDonald (2002) studied the effect of ionic strength to enthalpy and liposome – 
DNA complex formation. They titrated cationic liposomes to a DNA solution and DNA 
to cationic liposomes. The buffers contained 20 mM HEPES, 0.1 mM EDTA and different 
amounts of NaCl. They found out that at low ionic strength the equilibrium DNA/lipid 
concentration ratio is higher than at high ionic strength. Pozharski and MacDonald 
(Pozharski and MacDonald 2002) studied also different types of cationic liposome 
composition, and their interaction with DNA. Nascimento et al. (2015) titrated siRNA to 
cationic liposomes with and without a hyaluronic acid coat. 
 
 
3 AIM OF THE STUDY 
 
This research work is aimed to develop and characterize innovative poly-cationic 
liposomal platforms for gene delivery, using a novel synthetic cell-penetrating enhancer. 
Liposomes are surface-engineered with the CPE, obtaining a cationic charged 
formulation that will be then exploited for dsDNA loading.  
 
The study has three main characterization steps. The first step is to decorate liposomes 
with the novel CPE by post insertion to obtain preformed cationic vesicles. Increasing 
amounts of CPE are added to the lipidic formulation, measuring its encapsulation by zeta 
potential analysis: the higher the CPE ratio on the liposome surface, the more positive the 
zeta potential becomes. The second step involves oligonucleotide loading by a post 
insertion procedure. These formulation strategies are investigated in order to assess their 
effect on the loading capacity of the lipoplexes and to find the final formulation with the 
highest loading efficiency. The final step is to investigate the thermodynamics of the 
cationic liposome/oligonucleotide association by microcalorimetric studies. 
 
  
23 
 
4 MATERIALS AND METHODS 
 
4.1 Novel cationic lipoplexes 
 
Novel cationic lipoplexes used in the experiments consists of cationic liposomes 
generated with two different lipids (phospholipid and cholesterol), a post-inserted 
cationic synthetic lipid that is developed and synthetized in the University of Padova, and 
an oligonucleotide. Figure 8 represents a diagram of the lipoplexes studied in this thesis 
work.  
 
 
Figure 8. Diagram representing the lipoplex generated in this thesis work. In grey the lipid 
bilayer forms the liposome, in blue the cationic synthetic lipids are inserted into the lipid 
bilayer. The oligonucleotides (red) are adsorbed on the surface of the cationic liposomes. 
Image by Silvia Gallina, University of Padova. 
 
 The neutral lipids used to prepare the liposomes were egg phosphatidylcholine 
(EggPC, Lipoid E 80) that was purchased from Lipoid AG (Steinhausen / ZG 
Switzerland), and cholesterol from Sigma-Aldrich (St. Louis, MO, USA). The 
molecular structures of the main phospholipid component in EggPC and 
cholesterol are shown in Figure 9 and Figure 10, respectively.  
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Figure 9. Molecular structure of the main phospholipid component in EggPC.  (Lipoid 
GmbH 2016) 
 
 
Figure 10. Molecular structure of cholesterol.  (Sigma-Aldrich 2016) 
 
 The cationic and synthetic CPE used to provide for positive charge in the 
liposomes is a novel non-peptidic oligo-guanidyl derivative (OGD), which was 
conjugated to an unsaturated alkyl chain (length 18 carbon atoms) for liposome 
anchoring to the lipid bilayer. A previously synthetized OGD was developed after 
intensive study of the TAT (trans-activator of transcription) peptide and its 
derivatives in the University of Padova  (Bersani et al. 2012). In this study two 
varieties of OGD were used, one with 4 positive charges (OGD4) and the other 
with 6 positive charges (OGD6). The molecular weights of OGD4 and OGD6 are 
2266.59 g/mol and 3925.49 g/mol, respectively. A solution of the oligo-guanidyl 
moiety conjugated with a lipophilic side-chain was prepared either in HEPES or 
TRIS buffer.  
 Double stranded DNA (dsDNA) (biomers.net GmbH, Ulm, Germany) was used 
in this study as an oligonucleotide model to mimic small interfering RNA 
(siRNA). The dsDNA used contains 38 phosphate groups. 
 
Initially another lipid, hydrogenated soy phosphatidylcholine (HSPC, 
PHOSPHOLIPON® 80 H, Lipoid AG), was used instead of EggPC. The HSPC (shown 
in Figure 11) was chosen in the beginning because a combination of HSPC and 
cholesterol have been used in previous studies and in several commercial formulations 
such as Doxil® and Ambisome®  (Fan and Zhang 2013; Li et al. 2015). HSPC was 
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replaced with EggPC because the liposomes consisting of HSPC and cholesterol were not 
stable when assembled with OGD. EggPC was chosen because EggPC liposomes have 
proved to have a higher encapsulation efficiency and better drug carrying ability than soy 
phosphatidylcholine liposomes (Li et al. 2015). A commercial liposomal product 
Myocet® has EggPC in its lipid composition.  
 
Figure 11. The molecular structure of HSPC.  (Avanti Lipids Polar 2016) 
 
4.2 Buffer preparation 
 
All the aqueous buffer solutions were based on Milli-Q water (Merck Millipore KGaA, 
Darmstadt, Germany). A Seven Easy S20-K Mettler Toledo pH meter with a Mettler 
Toledo Inlab 413 electrode (Schwerzenbach, Switzerland) together with a Fischerbrand 
Hydrus600 pH meter were used to measure the pH. The pHs of the buffer solutions was 
adjusted by HCl and NaOH solutions. The following buffers were used in the experiments 
unless otherwise stated. 
 The main buffer used in the experiments was a HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) buffer solution at pH 7.4 to mimic neutral pH 
conditions (10 mM HEPES (Sigma-Aldrich) and 150 mM of NaCl) with isotonic 
osmotic pressure. The molecular structure of HEPES is shown in Figure 12. 
 
Figure 12. Molecular structure of HEPES. 
             
 The citrate buffer was used to mimic acidic endosomal conditions at pH 5.0 
(Sorkin and von Zastrow 2002). It was prepared by using 80 mM trisodium citrate 
dehydrate (Carlo Erba Reagents SAS, Val de Reuil, France) to create an isotonic 
buffer. The molecular structure of trisodium citrate dehydrate is shown in Figure 
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13. No NaCl was added to this buffer because the ionic strength was already 
sufficiently high. 
 
Figure 13. Molecular structure of trisodium citrate dihydrate 
             
 TRIS buffer at pH 7.4 was used in isothermal titration calorimetry (ITC) 
measurements. The TRIS buffer contained 10 mM 2-Amino-2-(hydroxymethyl)-
1,3-propanediol base (TRIS, Sigma-Aldrich) (structure shown in Figure 14), 1 
mM ethylenediaminetetraacetic acid (EDTA, Sigma-Aldrich) and 50 mM NaCl. 
TRIS was chosen because it was the annealing buffer of the dsDNA. 
 
Figure 14. Molecular structure of TRIS 
 
 A concentrated electrophoresis buffer (TBE) was prepared by using 1 M TRIS, 1 
M boric acid (Merck Millipore KGaA) and 20 mM EDTA and Milli-Q water. The 
pH of the buffer was adjusted to 7.4. The running buffer for electrophoresis 
measurements was prepared by diluting the TBE buffer ten times by using 
deionized water. 
 
Since the buffers affect the different characterization methods it is important to determine 
parameters such as ionic strength (Varenne et al. 2015). The physico-chemical properties 
of the buffers are presented in   
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Table 1 and these were calculated by using the equations below (Sinko and Singh 2011b; 
Sinko and Singh 2011c; Sinko and Singh 2011a). The ionic strength I is defined as 
 
𝐼 =
1
2
∑
𝑐𝑖
𝑐0
𝑧𝑖
2,
 
𝑖
 
(5) 
where ci is the concentration, c0 mol/L and z the charge of the ion in units elementary 
charge e, respectively  (Sinko and Singh 2011b).  
The buffer capacity β is given by 
 
𝛽 = 2.3 𝐶 
𝐾𝑎[𝐻3𝑂
+]
(𝐾𝑎 +  [𝐻3𝑂+])2
 
(6) 
and the maximum buffer capacity βmax is obtained when [H3O+] = Ka, i.e. when pH is 
equal to the acid dissociation constant pKa, which yields 
 𝛽𝑚𝑎𝑥 = 0.576 𝐶, (7) 
where C is the total concentration of the buffer  (Sinko and Singh 2011a). 
The apparent acid dissociation constant pKa’ is determined by using the Debye-Hückel 
relationship 
 
𝑝𝐾𝑎
′ = 𝑝𝐾𝑎 + (2𝜀 − 1) [
𝐴√𝐼
1 +  √𝐼
− 0.1𝐼], 
(8) 
where ε is the charge on the conjugate acid species and A the temperature dependent 
constant that is 0.51 at 298 K. The ionic strength of the solutions affects the acid 
association constant and thus the buffer capacity. Therefore, it is important to determine 
the pKa’ and the apparent buffer capacity (apparent β) which take the ionic strength into 
consideration. The apparent β can be determined with Equation 6 but with Ka’ used 
instead of Ka.  
 
Biochemical properties of the buffers should match those of human blood as the ultimate 
objective is to use this method for gene delivery in humans. The osmotic pressure π of 
blood is 7.7 atm. It can be calculated for electrolyte solutions by using van’t Hoff’s 
formula  
 𝜋 = ∑ 𝑐𝑘𝑖𝑘𝑅𝑇,
𝑘
  (9) 
where ck is the concentration of the k
th salt in the solution, and ik is the corresponding 
correction factor that approaches the number of ions the salt dissociates in dilute solution 
(Sinko and Singh 2011c).  
28 
 
Table 1. Significant physico-chemical parameters of HEPES, TRIS and citrate buffers. 
The pKa values for HEPES and TRIS are from Sigma-Aldrich and for citrate from Carlo 
Erba Reagents. 
 HEPES pH 7.4 TRIS pH 7.4 citrate pH 5 
pKa 7.50 8.07 4.76 
pH range 6.8–8.2 7.5–9.0 3.0–6.2 
Buffer salt concentration (mol/L) 0.01 0.01 0.08 
Maximum buffer capacity βmax 0.0058 0.0058 0.0461 
NaCl concentration (mol/L) 0.15 0.05 0 
EDTA concentration (mol/L) 0 0.001 0 
Ion strength I 0.160 0.068 0.480 
Apparent pKa' 7.37 8.17 4.60 
β at chosen pH 0.0057 0.0033 0.0427 
Apparent β 0.0057 0.0029 0.0374 
Osmotic pressure (atm) 7.829 3.034 7.829 
Suggested working concentration 
(mol/L) (Sigma-Aldrich) 0.01–1 0.01–0.0625  – 
 
4.3 Liposome preparation and different characterization methods  
 
The lipid stock solutions were obtained by dissolving the lipids in a mixture of chloroform 
and methanol (Sigma-Aldrich). The concentrations of the lipid solutions were 6.45 
mg/mL and the molar ratio of chloroform and methanol was 1:2. The phospholipid-
cholesterol mixture was prepared by mixing the stock solutions of lipids in a round bottom 
flask with a 2:1 EggPC/cholesterol molar ratio. The solvents methanol and chloroform 
were then evaporated by using a vacuum rotary evaporator system (Büchi R-114, Büchi 
Labortechnik AG, Flawil, Switzerland) at 25–30 °C, so that a thin lipid film was formed 
on the wall of the flask. To ensure that all the organic solvents were evaporated the flask 
was placed into a desiccator which was attached to a vacuum pump (Büchi Vac V-500) 
for at least 4–5 hours.  
 
The lipid layer was re-hydrated in 200–400 µL of buffer solution and vortexed. Then the 
liposomes were subjected to freeze-thaw cycles prior to extrusion to obtain monodisperse 
particle profiles (Castile and Taylor 1999). The freezing was done in liquid nitrogen and 
the thawing in glycerol at 65 °C, and the cycle was repeated 10 times. After the freeze-
thawing cycles buffer was added to form a solution with a lipid concentration of 20 
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mg/mL (16 mg/mL of EggPC and 4 mg/mL of cholesterol). The liposome solution was 
then sonicated in an ultrasonic bath (Power Sonic410, Hwashin Technology CO, Seoul, 
Korea) for 10 minutes at 37 °C to further narrow down the particle size distribution. Then 
the liposomes were extruded 11 times with a 200 nm cut-off filter by using an Avanti 
Polar mini-extruder (Alabaster, AL, USA). The same procedure was used with all three 
buffers. This whole procedure is shown and explained in Figure 15. 
 
 
Figure 15. Schematic depiction of liposome preparation from lipid stock solutions (Lopes 
et al. 2013, p. 95). 
 
4.3.1 Post-insertion of oligo-guanidyl derivative 
 
An oligo-guanidyl derivative solution was prepared by dissolving 3 mg/mL of OGD 
powder in buffer solution. Since OGD was not soluble at pH 5 it was solubilized at pH 
7.4, by using either the TRIS or HEPES buffer. The solution was sonicated by using a 
probe-type sonicator (Omni-Ruptor 250, Ultrasonic homogenizer, Omni Inc., Kennesaw 
GA, USA) for 15 minutes. The appropriate amount (see below) of OGD solution was 
added to 150–250 µL of extruded liposomes (20 mg/mL). The liposome/OGD mixture 
was vortexed after each 200 µL of added OGD. The total amount of OGD was 392-654 
µL and 317-529 µL for OGD4 and OGD6, respectively, to obtain different mol-%. The 
final cationic liposome concentration of 3–5 mg/mL was reached by adding a suitable 
volume of either HEPES, TRIS or citrate buffer. 
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4.3.2 Post-insertion of double stranded DNA 
 
After determining the best mol-% of OGD to create cationic liposomes, different amounts 
of dsDNA were added to the optimized cationic liposomes to assess the maximum amount 
of dsDNA that binds to them as a proxy for dsDNA loading. The dsDNA was added to 
the diluted cationic liposomes and the samples were vortexed and maintained at room 
temperature for 30 minutes to promote the dsDNA association with the cationic 
liposomes. Different nitrogen/phosphate (N/P) ratios were prepared by adding increasing 
amounts of 10 µM or 100 µM dsDNA solution to 20 µL of cationic liposomes containing 
17 nmol of OGD4 or 8.08 nmol of OGD6. “N” represents the cationic nitrogen in the 
guanidinium groups of the OGDs while “P” represent the phosphate groups in the dsDNA 
macromolecule.  The amount of dsDNA that was added to the liposomes was calculated 
by using the following equation: 
   
𝑛𝑂𝐷𝐺
𝐸 × 
𝑁
𝑃
= 𝑛𝑑𝑠𝐷𝑁𝐴, 
(10) 
where E is the ratio of the positive charges in the OGD and the negative charges in the 
dsDNA. Since the dsDNA possesses 38 negative charges (19 base pairs) and the OGD 
has either 4 or 6 positive charges, E was either 9.5 (OGD4) or 6.33 (OGD6), respectively. 
The cationic liposome lipid concentration in the sample was diluted to 0.1 mg/mL by 
using the buffer that was used to prepare the liposomes. The dsDNA association 
measurements were performed in 10 mM HEPES (pH 7.4), 10 mM TRIS (pH 7.4), and 
80 mM citrate (pH 5.0) buffers.  
 
4.3.2 Size and zeta potential measurements with dynamic light scattering 
 
The size and zeta potential of the cationic liposomes were measured by dynamic light 
scattering (DLS) by using a Zetasizer NanoZS instrument (Malvern Instruments, 
Malvern, Worcestershire, UK). Disposable cuvettes were used for size measurements 
(ZEN0010, Malvern) and for zeta potential measurements (either DTS1070 or 
DTS1060/DTS1061, Malvern).  
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The DLS measurements were performed at 25 °C. When size measurement was 
performed, the equilibration time was 120 seconds, the scattering angle was 173° and 5 
measurements per sample were carried out. The number of runs was on automatic setting 
and the delay between measurements was 5 seconds.  
 
The zeta potential measurements were analyzed according to the Smoluchowski model 
and the equilibration time was set to 120 seconds. The duration of each measurement was 
automatic from 10 to 100 runs, 3 measurements were always recorded from one sample 
and the delay time was set to 0 seconds. 
 
The size and zeta potential measurements were first performed in HEPES buffer (pH 7.4) 
on cationic liposomes formulated with different amount of OGD. For these 
measurements, the concentration of the naked liposomes was always either 0.5 (OGD4) 
or 1 (OGD6) mg/mL. The OGD percentage (of the total liposome mass) was 8–15.5 % 
for OGD4, and 2.5–10 % for OGD6, depending on the sample. The goal of the 
measurements was to identify the best ODG percentage on liposomes that yields a suitable 
size and zeta potential before adding the dsDNA for post insertion.  
 
After these measurements, the aim was to find out the highest stable N/P ratio by adding 
different amounts of dsDNA solution to the cationic liposomes. A 0.1 mg/mL liposome 
concentration was used for dsDNA association studies. 
 
The lipoplex stability was measured by DLS for 14.5 hours at 37 °C by measuring the 
size every half an hour. The colloidal stability study was repeated 3 times with HEPES 
buffer and 3 times with 15 % of fetal bovine serum (FBS) added to the HEPES buffer 
samples.  
 
4.3.3 Electrophoretic mobility shift assay 
 
The gel electrophoresis experiments were used to assess the affinity of dsDNA with the 
cationic liposomes. The experiments were performed with cationic liposomes at pH 7.4 
by using a 10 mM TRIS buffer, and at pH 5.0 in an 80 mM citrate buffer. The gel running 
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buffer at pH 7.4 was TBE as described earlier. The cationic liposomes were prepared as 
explained above with either 10 % or 5 % of OGD4 or OGD6, respectively, of the total 
lipid content. The different N/P ratios were obtained by using 10 µL of cationic liposomes 
further diluted to the required concentrations and by adding either 2.58 µL (OGD4 
samples) of a solution containing 300 ng (corresponding to 2.58×10-11 mol) of dsDNA or 
2.68 µL (OGD6 samples) of a solution containing 311 ng (2.68×10-11 mol) of dsDNA.  
The N/P ratios for OGD4 and OGD6 decorated liposomes were from 1:1.0, to 1:12, and 
from 1:0.5 to 1:10, respectively. The OGD4 and OGD6 concentrations in 10 µL of 
liposome dispersions were 0.056–1.11 mg/mL and 0.032-0.65 mg/mL, respectively. The 
cationic liposome concentrations were 0.14–1.7 mg/mL and 0.10-2.0 mg/mL for OGD4 
and OGD6 liposomes, respectively. The amount of OGDs in cationic liposomes was 
calculated with Equation 10.  
 
10 mL of a polyacrylamide gel was prepared at 12 w/v % concentration of acrylamide 
monomer from 4 mL of 30 w/v % acrylamide/bisacrylamide (29:1) in water solution, 2.5 
mL of 0.1 M TBE and 2 mM EDTA buffer pH 7.4, 0.1 mL of 10 w/v % ammonium 
persulfate (APS) in water, 4 µL of N,N,N′,N′-tetramethylethylenediamine (TEMED, 
0.775 g/mL) and 3.4 mL of deionized water. The APS and TEMED were used as 
polymerization agents of the gel. The gel electrophoresis assay was also performed at pH 
5.0 by using the 80 mM citrate buffer instead of the TBE buffer. 
 
Nine of the ten polyacrylamide gel wells received 15.08 µL of the different samples. Each 
sample contained 2.5 µL bromophenol blue. The wells were always filled in the same 
order. The first well was left empty. In the OGD4 electrophoretic assay the second well 
received the ladder (GeneOn GmbH, Germany). The third well received the positive 
control containing 2.58 µL of dsDNA and 10 µL of either TRIS buffer with pH 7.4 or 
citrate buffer with pH 5.0. The fourth well received the negative control containing 2.58 
µL of buffer and 10 µL of cationic lipids with 5 mg/mL and 1.96 mg/mL of liposomes 
and OGD4, respectively. The remaining wells received lipoplexes with different N/P 
ratios. In the OGD6 electrophoretic assay the dsDNA volume was always 2.68 µL, and 
the second well received the positive control, third well the negative control (10 µL 
liposomes and 2.68 µL buffer), and the following 6 wells received lipoplexes with 
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different N/P ratios. In the positive control the concentration of OGD6 was 1.59 mg/mL 
in 5 mg/mL of liposomes. The gel electrophoresis was performed with an Amersham 
Biosciences miniVE Electrophoresis and Electrotransfer Unit system (GE Healthcare; 
Milan, Italy). In the OGD4 electrophoretic assay the gel was run for either 2 hours at 100 
mV at pH 7.4 or 1.25 hours at pH 5.0. In the OGD6 electrophoretic assay the gels run for 
1 hour. Afterwards the gel was placed for 20 minutes in a staining medium containing the 
DNA intercalating agent Gel Red® 10000× that was diluted 3300 times with milli-Q 
water to make a 3× staining solution. The gel images were obtained with the UV 
transilluminator ChemiDoc™ XRS + imaging system with Image Lab™ image 
acquisition and analysis software (Bio-Rad Laboratories, Headquarters, CA).  
 
4.3.4 Isothermal titration calorimetry 
 
Isothermal titration calorimetry (ITC) was used to study the thermodynamics of the 
interaction between the dsDNA and the cationic liposomes in TRIS buffer. The 
measurements were performed by using a Malvern MicroCal, LLC VP-ITC 
microcalorimeter system (Worcestershire, UK). 
 
In the preliminary attempts, dsDNA concentration in the syringe was set at 20 µM. The 
starting concentration of OGD4 in the sample cell was 0.612 mg/mL corresponding to 
270 µM, the injection volume was 10 µL and 25 injections were performed. The interval 
between the injections was 300 s. In a second attempt the interval was kept the same, the 
concentration of OGD4 was decreased to 0.490 mg/mL (216 µM) and the injection 
volume to 5 µL, with 52 injections. After that the injection volume was further increased 
to 8 µL and the interval between the injections to 350 s. The results of these attempts were 
not satisfactory because the OGD4 concentrations were too high and the reaction did not 
reach the saturation. Based on these preliminary attempts the final settings for the 
measurements reported below were selected. 
 A volume of 280 µL of 20 µM dsDNA solution was placed in a titration syringe. 
The 1.5 mL sample cell was filled with 0.62 mg/mL of cationic liposomes with 
an OGD4 concentration of 0.245 mg/mL corresponding to 108 µM. The 1.5 mL 
reference cell was filled with the same buffer that was used to prepare the samples.  
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 The second measurement was a control made with dsDNA to measure the 
interaction of the dsDNA and the buffer. The sample cell was filled with the same 
buffer as the reference cell and the same amount of dsDNA solution was placed 
into the syringe.  
 The third measurement was a control made with naked liposome to assess 
thermodynamic contribution of diluting naked liposomes with buffer. For this 
measurement, the reference and sample cells were filled with the buffer. The 
syringe was loaded with 280 µL of naked liposome with a concentration of 0.62 
mg/mL corresponding to 0.97 mM.  
The sample cell temperature was set to 25 °C, the stirring speed was 351 rpm, and the 
interval between the injections was 400 s. One measurement included 32 injections which 
lasted 10 seconds each. Each injection contained 8 µL of either dsDNA solution or naked 
liposomes.  
 
The final ITC settings were also used with two HEPES buffers containing 10 mM HEPES 
and different amount of NaCl, i.e. 150 mM or 50 mM. However, these results were not 
satisfactory and only the ITC measurements performed with TRIS buffer are discussed in 
this thesis. 
 
 
5 RESULTS 
 
5.1 Dynamic light scattering results for OGD4 
 
First the size and zeta potential of liposomes that contain different amounts of oligo-
guanidyl derivatives were measured. The purpose of these measurements was to find the 
lowest OGD4 molar ratio that results in a sufficient zeta potential to encourage the 
attachment of dsDNA to the lipoplex, and a low polydispersity index (PDI) to obtain a 
narrow particle size distribution. The results shown in Table 2 and Figure 16 were 
gathered together with Anna Balasso from University of Padova. The samples with a total 
lipid concentration of 0.5 mg/mL were prepared in HEPES buffer at pH 7.4. The size 
distribution results are based on the intensity instead of Z-average because the PDI of 
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some samples was higher than 0.3, and therefore the average distribution of intensity, 
volume and number measurements would not be accurate (NanoComposix 2015). From 
these results the mol-% of OGD4 in liposomes for further studies was chosen to be 10 % 
because this sample had the lowest PDI range, a sufficiently small particle size, and a 
suitably high zeta potential. 
 
Table 2. Size, zeta potential, and polydispersity index (PDI) for liposomes with different 
mol-% of post-inserted OGD4. The measurements were made in HEPES buffer at pH 7.4 
and the total lipid concentration of the sample was 0.5 mg/mL. Results obtained together 
with Anna Balasso, University of Padova.  
Percentage of OGD4 PDI Size (nm) Zeta potential (mV) 
0.00 % 0.21 186.07 ±4.87 0.58 ±2.37 
8.00 % 0.40 164.53 ±1.46 12.37 ±0.51 
10.00 % 0.33 172.77 ±6.62 14.17 ±0.93 
12.00 % 0.37 163.77 ±38.49 17.70 ±0.90 
13.00 % 0.35 185.80 ±7.15 18.30 ±0.95 
15.50 % 0.35 232.63 ±63.06 18.30 ±0.92 
 
 
Figure 16. Size and zeta potential for liposomes with different mol-% of OGD4. The 
measurements were made in HEPES buffer at pH 7.4 and the total lipid concentration of 
the sample was 0.5 mg/mL. The bars show the size of the liposomes and the line 
represents the zeta potential values. Results obtained together with Anna Balasso, 
University of Padova. 
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Figure 17 shows the size results of the cationic OGD4 liposomes containing different 
amounts of dsDNA. Figure 18 shows the corresponding PDI values. The dsDNA 
complexed with cationic liposomes as soon as it was added to them.  The results were 
measured in different buffers: HEPES and TRIS at pH 7.4, and citrate at pH 5. The total 
lipid concentration of the sample was 0.1 mg/mL. The nitrogen/phosphate ratio (N/P 
ratio) of the liposome formulation is equal to the ratio between the total positive charge 
from the oligo-guanidyl derivatives and the total negative charge from the dsDNA. When 
liposomes are plain there is no dsDNA and the amount of dsDNA increases when the N/P 
ratio decreases. Figure 19 shows the zeta potential results of lipoplexes with different N/P 
ratios. These measurements were performed only in HEPES and TRIS buffers at pH 7.4. 
In the TRIS buffer the size and zeta potential were also measured at N/P ratio 2, where 
the size was 867.16 ± 541.04 nm and the zeta potential 19.23 ± 0.86 mV. It can be seen 
that all the positive charges were compensated when the N/P ratio was between 5–7.5 in 
HEPES buffer and 1–4 in TRIS buffer, as this is where the zeta potential approaches zero.  
 
 
Figure 17. The size of the lipoplexes in different buffers. The figure shows the size versus 
N/P ratio. The total lipid concentration of the sample lipids was 0.1 mg/mL. The amount 
of the dsDNA is increasing as the N/P ratio decreases. The plain liposomes do not contain 
any dsDNA.  Lipoplexes in HEPES buffer pH 7.4 (blue bars), TRIS buffer pH 7.4 (green 
bars) and citrate buffer pH 5 (red bars). 
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Figure 18. The polydispersity index of the size results. Each N/P ratio has the PDI results 
for lipoplexes in HEPES buffer pH 7.4 (blue bars), TRIS buffer pH 7.4 (green bars) and 
citrate buffer pH 5 (red bars). The total lipid concentration of the sample was 0.1 mg/mL. 
The amount of the dsDNA is increasing as the N/P ratio decreases. The plain liposomes 
do not contain any dsDNA.   
 
 
Figure 19. Lipoplex zeta potential in HEPES buffer (blue line) and TRIS buffer (green 
line). The total lipid concentration of the sample was 0.1 mg/mL. The amount of the 
dsDNA is increasing as the N/P ratio decreases. The plain liposomes do not contain any 
dsDNA. 
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Figure 20 shows the result of the stability experiment where the lipoplex size was tracked 
as a function of time. The buffer used in this experiment was HEPES (pH 7.4), the N/P 
ratio was 10, the total lipid concentration of the sample was 0.1 mg/mL, and the 
temperature was 37 °C. Under these conditions the lipoplexes were found to be stable. 
The experiments were then repeated with 15 % of FBS added to the suspension. The 15 
% of FBS is the usual amount used in cell media. As can be seen from the results shown 
in Figure 21, in this case the lipoplexes were no longer stable. Both stability experiments 
were repeated 3 times and the results show the average value and standard deviation of 
each time point. 
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Figure 20. Lipoplex stability at 37 °C (N = 3). The measurements were recorded every half an hour for 14.5 hours. They were made in HEPES 
buffer, with an N/P ratio of 10, and a total lipid concentration of 0.1 mg/mL.  
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Figure 21.  Lipoplex stability at 37 °C with 15 % of FBS (N = 3). The measurements were taken every half an hour for 14.5 hours. They were 
made in HEPES buffer, with an N/P ratio of 10, a total lipid concentration of 0.1 mg/mL. 
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5.2 Electrophoretic mobility shift assay for OGD4 
 
Two electrophoretic mobility shift assays were performed, one (gel A) at pH 7.4 using 
the TBE buffer to run the electrophoresis, and the other (gel B) at pH 5.0 using 80 mM 
citrate buffer. The liposomes were prepared in 10 mM TRIS buffer (pH 7.4) or 80 mM 
citrate buffer (pH 5.0), respectively. Figure 22 shows the electrophoretic profiles of the 
gels. At pH 7.4 one can see that there was some free dsDNA remaining when the N/P 
ratio was smaller than 3, and all the dsDNA was attached to the OGD on the liposome 
surface when the N/P ratio was 5 or greater. At pH 5 the profile is very similar except that 
there is no free dsDNA remaining when the N/P ratio was 3 or greater. This means that 
more dsDNA was needed to compensate all the cationic charges in the citrate buffer with 
pH 5. 
 
 
Figure 22. Electrophoretic mobility profiles of dsDNA mixed with OGD4-coated 
liposomes (A) at pH 7.4 and (B) at pH 5. 
 
 
5.3 Isothermal titration calorimetry for OGD4 
 
The dsDNA and cationic liposome interaction thermodynamics were measured by using 
isothermal titration calorimetry (ITC), in which dsDNA was titrated into cationic 
liposomes. The measurement temperature was 298 K (25 °C). Figure 23 shows the raw 
ITC data that was processed and fitted by using the AFFINImeter software (Santiago de 
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Compostela, Spain) to obtain the thermodynamic parameters of the interaction between 
dsDNA and OGD4 liposomes. Figure 24 represents the resulting ITC profile. The 
cumulative heat curve was plotted against the dsDNA/OGD4 molar ratio. Figure 25 
shows the ITC profiles of (A) dsDNA and (B) naked liposomes titrated into the buffer. 
There is no noticeable interaction between the counter ions of the buffer and either the 
dsDNA or the naked liposomes. We therefore can conclude that the buffer and the naked 
liposomes did not significantly influence the thermodynamics of the dsDNA ‒ OGD4 
interaction.   
 
 
Figure 23. The raw ITC data that was processed and fitted to obtain the thermodynamic 
parameters of the interaction between dsDNA and OGD4 liposomes.  
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Figure 24. Cumulative heat obtained from the calorimetric titration of 20 µM solution of 
dsDNA (8 µL/injection) into cationic liposomes that contained 108 µM of OGD4. The 
figure shows the reaction enthalpy versus the dsDNA/OGD4 molar ratio (blue bars) and 
the fitted curve (orange line) to obtain the thermodynamic parameters for the interaction.  
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Figure 25. The ITC profiles of (A) dsDNA and (B) naked liposomes titrated into a buffer solution. The upper panels show the raw data and 
the lower panels show the binding enthalpy of each titration. The concentrations for dsDNA and naked liposomes were 0.02 mM and 0.97 
mM, respectively.    
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The thermodynamic parameters of the dsDNA titration into the cationic liposomes were 
determined by fitting the ITC data to a chemical interaction model with 2 set of sites.  The 
global parameters Qdil and rM were also fitted to get these results. The parameters are 
shown in Table 3. Qdil corrects the molar enthalpy of dilution of the injected solution 
when control titration has not been subtracted from the experimental data. rM corrects the 
possible differences between nominal and true concentration of lipids. The concentration 
difference may be the result of using the OGD4 concentration instead of the total 
liposome concentration in the cell. The χ2 (chi square) value represents the quality of the 
fit. The cationic liposomes have a high positive charge and are surrounded by the counter 
ions of the buffer, before the dsDNA replaces them. Each set of fit parameters consists of 
a binding constant Ka, a stoichiometry parameter N, and a molar enthalpy change ∆H. By 
using the fitted parameters, we may calculate other quantities describing the reaction: the 
dissociation constant  
 
𝐾𝑑 =
1
𝐾𝑎
 
(11) 
of the reaction, the molar Gibbs free energy change  
 ∆𝐺 =  𝑅𝑇 ln 𝐾𝑑 , (12) 
where R is the gas constant and T the absolute temperature, and the molar reaction entropy 
 
∆𝑆 =  
∆𝐻 −  ∆𝐺
𝑇
. 
(13) 
 
We expect the first set of parameters to describe the dsDNA/OGD4 reaction. N1 is roughly 
the phosphorous/nitrogenous (P/N) ratio of OGD4 and dsDNA at the saturation point.  
Since ∆H1 was positive and ∆G1 was negative, the reaction was endothermic and 
spontaneous, respectively (Sinko and Singh 2011b). The molar entropy change ∆S1 is due 
to the movement of the counter ions during the dsDNA binding to OGD4 (Ziegler and 
Seelig 2007). The reaction was entropy driven because the molar enthalpy change ∆H1 
was smaller than T∆S1 (24400 cal/mol) (Bouchemal and Mazzaferro 2012; Wettig 
andKamel 2013). The second set of parameters is responsible for the drop in the heat 
curve in Figure 24, and should correspond to a secondary reaction (e.g. aggregation). 
 
The enthalpy reaches its maximum when the maximal amount of dsDNA is bound to the 
cationic liposomes. The N/P ratio at the maximum was calculated from the dsDNA and 
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OGD4 concentrations using Equation 10 and was found to be 4.4. The calculations are 
included in APPENDIX A: . Towards the end of the titration when the enthalpy change 
was again low, no more dsDNA could bind to the cationic liposomes and any additional 
dsDNA remained free in the solution. 
 
Table 3. Fitting parameters for the ITC enthalpy curve: reaction stoichiometry N, affinity 
constant Ka and molar enthalpy change ∆H. Additionally two global fitting parameters 
were used: the molar enthalpy of dilution Qdil and the lipid concentration correction 
coefficient rM. The dissociation constant Kd, molar reaction entropy ∆S, and molar Gibbs 
free energy change ∆G were computed from the fitted parameters as explained in the text.  
Set one parameters 
  
Set two parameters   
N1 0.23 ± 0.01 N2 0.46 ± 0.02 
Ka1 (L/mol) 7.3×108 ± 8.6×107 Ka2 (L/mol) 9.3×109 ± 3.7×109 
Kd1 (mol/L) 1.4×10-9  Kd2 (mol/L) 1.1×10-10  
ΔH1 (cal/mol) 12300 ± 536 ΔH2 (cal/mol) 1450 ± 165 
ΔS1 (cal/(K mol)) 81.9  ΔS2 (cal/(K mol)) 50.4  
ΔG1 (cal/mol) -12100 
 
ΔG2 (cal/mol) -13600  
Qdil (cal/mol) 1300 ± 12 rM 0.034 ± 9.0×10-4 
Quality of the fit χ2 1.01    
 
5.4 Dynamic light scattering results for OGD6 
 
The characterization of the OGD6 was also started by measuring the size and zeta 
potential of liposomes that contained different amounts of OGD6. These measurements 
were performed in HEPES (pH 7.4) buffer, and the total lipid concentration of the sample 
was 1 mg/mL. These results are shown in Table 4 and Figure 26. For further studies the 
mol-% of OGD6 in liposomes was chosen to be 5 %. This was the smallest amount of 
OGD6 that yielded a sufficiently high zeta potential, and had a reasonably low PDI. The 
liposome size did not show a strong dependence on the OGD6 percentage.  
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Table 4. Size and zeta potential measurements, and polydispersity index (PDI) for 
liposomes with different mol-% of OGD6. The measurements were done in HEPES 
buffer at pH 7.4 and the total lipid concentration of the sample was 1 mg/mL. 
Percentage of 
OGD6 PDI Size (nm) Zeta potential (mV) 
0.00 % 0.28 189.24 ±6.00 -3.31 ±1.27 
2.50 % 0.24 203.72 ±9.02 7.28 ±0.65 
5.00 % 0.21 200.00 ±6.67 15.03 ±0.76 
7.50 % 0.19 201.58 ±4.98 18.13 ±0.29 
10.00 % 0.29 190.24 ±9.43 18.83 ±0.35 
 
 
Figure 26. Size and zeta potential for liposomes with different mol-% of OGD6. The 
buffer was HEPES, and the total lipid concentration of the sample was 1 mg/mL. The 
bars show the size of the liposomes and the line represents the zeta potential. 
 
Figure 27 shows the size and zeta potential of the cationic OGD6 liposomes that contained 
different amounts of dsDNA, measured in HEPES (pH 7.4) buffer. Figure 28 represents 
the corresponding size and zeta potential measurements in citrate buffer at pH 5. Figure 
29 shows the PDI values for the size results of OGD6 lipoplexes. The N/P ratio describes 
the relation between the positive charge from the OGD6 and the negative charge from the 
dsDNA. It can be seen in Figure 27 that all the positive charges are compensated when 
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the N/P ratio is between 1–2.5 in HEPES (pH 7.4) buffer, as this is where the zeta potential 
reaches zero.  
 
 
Figure 27. Size and zeta potential of the lipoplexes in HEPES buffer at pH 7.4 as a 
function of the N/P ratio, with a total lipid concentration of 0.1 mg/mL. The amount of 
dsDNA is increasing as the N/P ratio decreases. The plain liposomes do not contain any 
dsDNA. The bars show the size of the lipoplexes and the line represents the zeta potential. 
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Figure 28. Size and zeta potential of the lipoplexes in citrate buffer at pH 5 as a function 
of the N/P ratio, with a total lipid concentration of 0.1 mg/mL. The amount of dsDNA is 
increasing as the N/P ratio decreases. The plain liposomes do not contain any dsDNA. 
The bars show the size of the lipoplexes and the line represents the zeta potential. 
 
 
Figure 29. The polydispersity index of the ODG6 size results. Each N/P ratio has the PDI 
results for lipoplexes in HEPES buffer at pH 7.4 (blue bars), and citrate buffer at pH 5 
(red bars). The total lipid concentration of the sample was 0.1 mg/mL. The amount of the 
dsDNA is increasing as the N/P ratio decreases. The plain liposomes do not contain any 
dsDNA.   
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5.5 Electrophoretic mobility shift assay for OGD6 
 
Two electrophoretic mobility shift assays were also performed for OGD6 liposomes. One 
(gel A) at pH 7.4 using the TBE buffer to run the electrophoresis, and the other (gel B) at 
pH 5.0 using 80 mM citrate buffer. The liposomes were prepared in 10 mM HEPES buffer 
(pH 7.4) or 80 mM citrate buffer (pH 5.0), respectively. Figure 30 shows the 
electrophoretic profiles of the gels. At pH 7.4 one can see that there was some free dsDNA 
remaining when the N/P ratio was smaller than 1, and all the dsDNA was attached to the 
OGD on the liposome surface when the N/P ratio was 3 or greater. At pH 5 the profile is 
the same as at pH 7.4. This means that the pH does not significantly affect how the OGD6 
liposomes can complex dsDNA. 
 
 
Figure 30. Electrophoretic mobility profiles of dsDNA mixed with OGD6 liposomes (A) 
at pH 7.4 and (B) at pH 5. 
 
 
6 DISCUSSION 
 
6.1 Characterization studies 
 
The focus of the characterization studies was to obtain the optimal cationic liposome 
composition for associating dsDNA in order to form a novel lipoplex for gene delivery. 
51 
 
Most of the characterization studies were performed on OGD4 liposomes because there 
were difficulties in synthetizing a sufficient amount of OGD6 lipids to perform all the 
planned studies. The characterization involved two steps: determining the optimal amount 
of OGD in the liposome, and then determining how much dsDNA can be associated with 
it. 
 
The hydrodynamic size of the particles was measured by DLS. According to the PDI 
values, both the OGD4 cationic liposomes and lipoplexes are either moderately (PDI 0.1–
0.4) or highly (PDI > 0.4) polydisperse (Bhattacharjee 2016), as can be seen in Figure 
16,Figure 17 andFigure 18. Based on the zeta potential measurement 10 % of OGD4 was 
used in the liposome composition. For lipoplexes the HEPES buffer resulted in the most 
consistent size and the lowest PDI (around 0.2), while the TRIS and citrate buffers yielded 
lipoplexes with a greater PDI and a size that varied more. Furthermore, the PDI of the 
citrate buffer lipoplexes was around 1 which means that the size measurement was 
unreliable and would need to be repeated to get adequate results, perhaps by using another 
method. The TRIS buffer lipoplexes were also quite polydisperse with a PDI around 0.5. 
The lipoplex zeta potential decreased to zero around an N/P ratio of 5 for HEPES and 
around an N/P ratio of 1 for TRIS.   
 
Figure 27Figure 28 andFigure 29 show the size measurement results and PDIs of OGD6 
liposomes and lipoplexes. The OGD6 liposomes had an overall lower PDI than the OGD4 
liposomes. Based on the zeta potential measurements, the optimal liposome composition 
was chosen to include 5 % of OGD6.  In HEPES buffer at pH 7.4 a simultaneous decrease 
in the zeta potential and an increase in size and PDI around the N/P ratio 1 were seen, 
which may be related to the positive charges being compeletely compensated. In the pH 
5 citrate buffer no such transition could be seen, and the zeta potential never reached over 
+6 mV.  
 
The size and zeta potential measurements were performed in three different buffers 
(HEPES, TRIS and citrate). The salt concentration of HEPES and citrate buffers were 
adjusted to create an isotonic osmotic pressure. The salt concentration for TRIS buffer 
was smaller than for HEPES or citrate buffers, and therefore the ionic strength and 
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osmotic pressure were also smaller as shown in Table 1. The ionic strength of the citrate 
buffer was 0.480 which was much larger than that of HEPES (0.160) and TRIS (0.068). 
The ionic strength can affect the zeta potential results and therefore the zeta potential 
results of citrate buffer lipoplexes should be used in a relative, not absolute sense 
(Kaszuba et al. 2010). The zeta potential results of OGD4 lipoplexes (Figure 19) showed 
that more dsDNA is needed to compensate the cationic charges of ODG4 liposomes when 
they are in a lower ionic strength (TRIS) buffer. This is due to the increase of the 
electrostatic interaction between the oppositely charged components of the complex  
(Kennedy et al. 2000). 
 
The electrophoretic mobility shift assay was performed by using the APS-TEMED 
system as the initiator to prepare the polyacrylamide gel. The APS-TEMED systems has 
an optimal polymerization performance when the pH is 7–10, and no polymerization at 
pH 4 (Caglio and Righetti 1993). With OGD4 in the citrate buffer the gel formation (at 
pH 5) was weak, and the resulting gel was more fluid than at pH 7.4. The methylene blue 
system could perform better at low pH (Caglio and Righetti 1993).  By comparing the 
electrophoresis results it can be seen that OGD4 lipoplexes were more pH dependent than 
OGD6 lipoplexes. At pH 5 OGD4 lipoplexes needed more dsDNA to compensate all the 
cationic charges than at pH 7.4, whereas OGD6 lipoplexes could bind the same amount 
of dsDNA at both pH values. 
 
The thermodynamic properties of dsDNA binding to the OGD4 liposomes were obtained 
by ITC. The fitted parameters are presented in Table 3. The large first binding constant 
indicates that the interaction between the dsDNA and OGD4 is electrostatic and strong.  
Similar observations were made by Nascimento et al. (2015) when they studied the 
interaction between cationic liposomes and siRNA by ITC. The binding reaction in this 
study was endothermic (∆H1 is 12300 ± 536 cal/mol) and entropy driven, as was also 
found in previous ITC experiments involving cationic liposomes and DNA (Kennedy et 
al. 2000; Pozharski and MacDonald 2002; Lobo et al. 2003). The global Qdil parameter 
(1300 ± 12 cal/mol) denoting the molar dilution enthalpy was compatible with the control 
titration in Figure 25 A.  After the saturation point of the reaction the electrostatic 
interactions and hydrogen bonds weaken and therefore the molar enthalpy change 
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decreases from 12300 to 1450 cal/mol. This can be explained by aggregation of the OGD4 
lipoplexes after the surface charge of the lipoplex becomes neutral (Kennedy et al. 2000). 
This explanation is also supported by the results in Figure 17 Figure 19 where the size of 
the TRIS buffer lipoplexes increased three times as the zeta potential approached zero 
around N/P ratio 1, respectively. The same phenomenon could also be seen with OGD6 
in HEPES buffer in Figure 27. 
 
All characterization studies were completed with the combination of OGD4 lipoplexes in 
TRIS buffer. The electrophoresis gel A in Figure 22 shows that below an N/P ratio of 5 
there is some free dsDNA left, and the ITC study yielded the compatible equilibrium N/P 
ratio of 4.4. Around N/P ratio 2 the lipoplex size started to increase, and the zeta potential 
decreased to zero around N/P ratio 1. Therefore, it seems that the optimal N/P ratio for 
the lipoplexes is around 5. 
 
6.2 Future perspectives 
 
In this study, we investigated the characteristics of the novel oligo-guanidyl cationic 
lipoplex developed for gene delivery. Since a high ionic strength distorts the zeta potential 
results, the zeta potential studies should be repeated using HEPES buffer without sodium 
chloride and the citrate buffer at pH 5 should be replaced with another suitable buffer for 
the corresponding pH in order to obtain  more reliable results. Also, the electrophoretic 
mobility shift assay at pH 5 should be repeated using the methylene blue system instead 
of APS-TEMED (Caglio and Righetti 1993). More complete ITC results could be 
obtained by repeating the titration a few times in both directions (dsDNA into OGD4 
liposomes and vice versa). The complete characterization of OGD6 lipoplexes also 
remains to be done.   
 
Instead of the post insertion method, another way to produce the cationic liposomes is to 
mix the OGD lipid together with EggPC and cholesterol stock solutions in the round 
bottom flask and prepare a thin lipid film containing both the neutral lipids and the 
cationic OGD lipid. Then the lipid film is rehydrated with dsDNA solution prior the ten 
freeze-thaw cycles, sonication, and extrusion. The lipoplexes prepared in this way should 
54 
 
be compared and contrasted with the lipoplexes prepared by post-insertion method in 
order to determine the best approach to prepare the lipoplexes for in vitro and in vivo 
studies. Also, a DNA release study remains to be performed on both types of lipoplexes.  
  
For further investigations, e.g.  release or cell studies with OGD4 lipoplexes with an N/P 
ratio of 4.4−5 are recommended because charge neutral lipoplexes aggregate easier and 
reduce the gene expression (Tros de Ilarduya et al. 2010). Also, for optimized stability 
the lipoplex surface should be slightly positive. In in vitro and in vivo studies it is 
important to avoid rapid elimination by RES e.g. by coating the liposomes with PEG 
(Nayerossadat et al. 2012). It would also be interesting to determine how the dsDNA is 
associated to the OGD and to the liposome, e.g. whether the dsDNA is encapsulated inside 
the cationic liposome or resides on the liposome surface. These morphological 
characteristics could be determined by using imaging techniques such as Transmission 
Electron Microscopy. 
 
 
7 CONCLUSION 
 
The focus of this study was to develop and characterize a novel poly-cationic liposomal 
platform for gene delivery. The novel synthetic non-peptide oligo-guanidyl derivative 
(OGD) was post inserted into the lipid bilayer and then characterized to obtain a liposome 
formulation that contains the smallest amount of OGD that results in sufficiently high 
zeta potential and uniform, sufficiently small size. The optimal formulation contained 
either 10 % of OGD4 or 5 % of OGD6 of the total lipid amount. The second step of the 
characterization studies was to find the smallest N/P ratio (the highest dsDNA loading) 
at which most of the cationic molecules were associated with dsDNA but a small positive 
charge remained on the lipoplex surface. DLS studies for OGD4 and OGD6 lipoplexes 
were performed in isotonic buffers, HEPES (pH 7.4) and citrate (pH 5) to mimic the 
conditions in human blood and cell endosome, respectively. The electrophoresis studies 
for both types of lipoplexes were performed in TBE (pH 7.4) and citrate buffers because 
TBE was used as the gel running buffer at pH 7.4. The ITC measurements were performed 
in non-isotonic TRIS buffer because it has a lower ionic strength than the isotonic HEPES 
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buffer, and TRIS was also used as annealing buffer for dsDNA. To obtain complete 
results for OGD4 lipoplexes, also the DLS, zeta potential and electrophoresis studies were 
performed in TRIS buffer. For further investigations, e.g.  release or cell studies, the 
optimal OGD4 lipoplexes were determined to have an N/P ratio of around 5. Further 
investigations would be needed to determine the best lipoplex composition and 
manufacturing method using an isotonic buffer in all the measurements excluding the zeta 
potential since the zeta potential results are not reliable when the ionic strength of the 
sample is high. 
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APPENDIX A: Isothermal titration calorimetry raw data 
 
Injection 
number
Initial 
volume 
(mL)
Injected 
volume 
(mL)
Final 
volume 
(L)
Initial 
concentratio
n in cell (mM)
Final 
concentratio
n in cell 
(mM)
Final 
amount of 
OGD4 
(mmol)
Final 
volume in 
cell (L)
Injected 
volume 
(mL)
Final 
volume in 
syringe 
(mL)
Final 
concentratio
n in cell 
(mM)
Final 
amount in 
cell 
(mmol)
N/P 
ratio in 
cell
dsDNA/
OGD4 
molar 
ratio
P/N 
ratio in 
cell
0 1.42 0 1.42E-03 0.1080 0.1080 1.54E-04 0 0 0.2796 0.00E+00 0 0 0.000 0.000
1 1.42 0.002 1.42E-03 0.1080 0.1078 1.54E-04 2.00E-06 0.002 0.2776 2.81E-05 4.00E-08 404.09 0.000 0.002
2 1.42 0.008 1.43E-03 0.1078 0.1074 1.54E-04 1.00E-05 0.008 0.2696 1.40E-04 2.00E-07 80.82 0.001 0.012
3 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.80E-05 0.008 0.2616 2.52E-04 3.60E-07 44.90 0.002 0.022
4 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.60E-05 0.008 0.2536 3.64E-04 5.20E-07 31.08 0.003 0.032
5 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 3.40E-05 0.008 0.2456 4.76E-04 6.80E-07 23.77 0.004 0.042
6 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 4.20E-05 0.008 0.2376 5.87E-04 8.40E-07 19.24 0.005 0.052
7 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 5.00E-05 0.008 0.2296 6.99E-04 1.00E-06 16.16 0.007 0.062
8 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 5.80E-05 0.008 0.2216 8.11E-04 1.16E-06 13.93 0.008 0.072
9 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 6.60E-05 0.008 0.2136 9.23E-04 1.32E-06 12.25 0.009 0.082
10 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 7.40E-05 0.008 0.2056 1.04E-03 1.48E-06 10.92 0.010 0.092
11 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 8.20E-05 0.008 0.1976 1.15E-03 1.64E-06 9.86 0.011 0.101
12 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 9.00E-05 0.008 0.1896 1.26E-03 1.80E-06 8.98 0.012 0.111
13 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 9.80E-05 0.008 0.1816 1.37E-03 1.96E-06 8.25 0.013 0.121
14 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.06E-04 0.008 0.1736 1.48E-03 2.12E-06 7.62 0.014 0.131
15 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.14E-04 0.008 0.1656 1.59E-03 2.28E-06 7.09 0.015 0.141
16 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.22E-04 0.008 0.1576 1.71E-03 2.44E-06 6.62 0.016 0.151
17 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.30E-04 0.008 0.1496 1.82E-03 2.60E-06 6.22 0.017 0.161
18 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.38E-04 0.008 0.1416 1.93E-03 2.76E-06 5.86 0.018 0.171
19 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.46E-04 0.008 0.1336 2.04E-03 2.92E-06 5.54 0.019 0.181
20 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.54E-04 0.008 0.1256 2.15E-03 3.08E-06 5.25 0.020 0.191
21 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.62E-04 0.008 0.1176 2.27E-03 3.24E-06 4.99 0.021 0.200
22 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.70E-04 0.008 0.1096 2.38E-03 3.40E-06 4.75 0.022 0.210
23 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.78E-04 0.008 0.1016 2.49E-03 3.56E-06 4.54 0.023 0.220
24 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.86E-04 0.008 0.0936 2.60E-03 3.72E-06 4.35 0.024 0.230
25 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 1.94E-04 0.008 0.0856 2.71E-03 3.88E-06 4.17 0.025 0.240
26 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.02E-04 0.008 0.0776 2.83E-03 4.04E-06 4.00 0.026 0.250
27 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.10E-04 0.008 0.0696 2.94E-03 4.20E-06 3.85 0.027 0.260
28 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.18E-04 0.008 0.0616 3.05E-03 4.36E-06 3.71 0.028 0.270
29 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.26E-04 0.008 0.0536 3.16E-03 4.52E-06 3.58 0.029 0.280
30 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.34E-04 0.008 0.0456 3.27E-03 4.68E-06 3.45 0.030 0.290
31 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.42E-04 0.008 0.0376 3.39E-03 4.84E-06 3.34 0.032 0.299
32 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.50E-04 0.008 0.0296 3.50E-03 5.00E-06 3.23 0.033 0.309
33 1.42 0.008 1.43E-03 0.1074 0.1074 1.54E-04 2.58E-04 0.008 0.0216 3.61E-03 5.16E-06 3.13 0.034 0.319
OGD4 liposomes in the cell dsDNA in the syringe
